2025
-$2.17
▼
Same method (see FY2016 and FY2023 records). CFO=$(85.541)M; reconciliation independently verified against the filing's own reconciliation: net income (pre-NCI) $(289.974)M + SBC $15.911M + D&A/impairment of long-lived assets $10.439M + goodwill impairment $412.611M (non-cash, DBC reporting-unit impairment tied to a sustained stock-price decline; correctly added back as sunk acquisition cost) - gain on sale of equity method investment $38.403M + amortization of debt premium $7.935M - changes in expected recoveries $176.451M (non-cash favorable re-estimate, stripped out) + deferred taxes $6.389M - net unrealized FX gain $13.084M + other $0.279M + ΔWC $(21.193)M = $(85.541)M, ties exactly to reported CFO. ΔWC so -ΔWC=$21.193M; SBC=$15.911M; PP&E capex=$4.821M; portfolio purchases=$1,203.740M vs recoveries applied to principal=$1,099.148M -> purchases exceed collections (book grew ~13% in 2025), net portfolio adjustment=$0. OE=-85.541+21.193-15.911-4.821=$(85.080)M. Diluted shares=39.173M. OE/sh=$(2.17). Note: consolidated CFO includes ~$15.2M of income attributable to noncontrolling interests (South American JV) not separately backed out; immaterial to the per-share conclusion. Source: FY2025 10-K, accession 0001185348-26-000006.
2024
-$3.38
▼
Same method (see FY2016 and FY2023 records). CFO=$(94.594)M, after a large non-cash 'changes in expected recoveries' reversal of $(240.868)M (a favorable, non-cash re-estimate of future collections that inflated GAAP net income but is stripped out starting from CFO, per this project's OE definition). ΔWC=$21.403M so -ΔWC=$(21.403)M; SBC=$13.470M; PP&E capex=$4.045M; portfolio purchases=$1,407.067M vs recoveries applied to principal=$1,027.896M -> purchases exceed collections, net portfolio adjustment=$0. OE=-94.594-21.403-13.470-4.045=$(133.512)M. Diluted shares=39.542M. OE/sh=$(3.38). Source: FY2024 10-K, accession 0001185348-25-000006.
2023
-$3.19
▼
Same method (see FY2016 record). CFO=$(97.535)M (negative; reconciles to net income $(66.754)M pre-NCI plus SBC $11.095M, D&A $18.615M, amortization of debt premium $9.223M, deferred tax $(35.942)M, FX $(16.552)M, other $(1.534)M, and ΔWC $13.448M -- 'changes in expected recoveries' add-back of only $29.134M this year, far smaller than 2024/2025, meaning less of the period's reported profit was a non-cash re-estimate); ΔWC=$13.448M so -ΔWC=$(13.448)M; SBC=$11.095M; PP&E capex=$2.887M; portfolio purchases=$1,160.289M vs recoveries applied to negative allowance=$917.025M -> purchases exceed collections (book growing again after the 2020-2022 pause), net portfolio adjustment=$0. OE=-97.535-13.448-11.095-2.887=$(124.965)M. Diluted shares=39.177M. OE/sh=$(3.19). Source: FY2023 10-K, accession 0001185348-24-000012.
2022
$3.20
▼
Same method (see FY2016 and FY2020 records). CFO=$21.592M; ΔWC=$(1.712)M so -ΔWC=$1.712M; SBC=$13.047M; PP&E capex=$13.251M; portfolio purchases=$844.255M vs recoveries applied to negative allowance=$974.846M -> shortfall of $130.591M added back as harvest. OE=21.592+1.712-13.047-13.251+130.591=$127.597M. Diluted shares=39.888M. OE/sh=$3.20. Source: FY2022 10-K, accession 0001185348-23-000007.
2021
$5.75
▼
Same method (see FY2016 and FY2020 records). CFO=$84.925M; ΔWC=$11.407M so -ΔWC=$(11.407)M; SBC=$15.940M; PP&E capex=$11.212M; portfolio purchases=$971.708M vs recoveries applied to negative allowance=$1,185.954M -> shortfall of $214.246M added back as harvest (continued light purchasing relative to collections). OE=84.925-11.407-15.940-11.212+214.246=$260.612M. Diluted shares=45.330M. OE/sh=$5.75. Source: FY2021 10-K, accession 0001185348-22-000005.
2020
$4.61
▼
Same method (see FY2016 record); FY2020 is the first year under CECL (negative-allowance) accounting, which changed income-statement mechanics but not the cash-flow-statement items this calc relies on. CFO=$141.704M; ΔWC=$32.523M (incl. right-of-use line) so -ΔWC=$(32.523)M; SBC=$14.387M; PP&E capex=$17.230M; portfolio purchases=$903.588M vs 'recoveries applied to negative allowance' (CECL-era label for collections applied to principal)=$1,037.659M -> purchases FELL SHORT of collections by $134.071M (company pulled back purchasing amid COVID-era uncertainty while continuing to collect the back book), so maintenance purchase=actual purchases and the $134.071M shortfall is added back as a real cash harvest. OE=141.704-32.523-14.387-17.230+134.071=$211.635M. Diluted shares=45.860M. OE/sh=$4.61. Source: FY2020 10-K, accession 0001185348-21-000006.
2019
$2.11
▼
Same method (see FY2016 record). CFO=$133.388M; ΔWC=$8.680M so -ΔWC=$(8.680)M; SBC=$10.717M; PP&E capex=$18.033M; portfolio purchases=$1,231.351M vs collections applied to principal=$842.910M -> purchases exceed collections, net portfolio adjustment=$0. OE=133.388-8.680-10.717-18.033=$95.958M. Diluted shares=45.577M. OE/sh=$2.11. Source: FY2019 10-K, accession 0001185348-20-000004.
2018
$1.09
▼
Same method (see FY2016 record). CFO=$80.866M; ΔWC=$2.362M so -ΔWC=$(2.362)M; SBC=$8.521M; PP&E capex=$20.521M; portfolio purchases=$1,105.759M vs collections applied to principal=$733.306M -> purchases exceed collections, net portfolio adjustment=$0. OE=80.866-2.362-8.521-20.521=$49.462M. Diluted shares=45.413M. OE/sh=$1.09. Source: FY2018 10-K, accession 0001185348-19-000009.
2017
$0.35
▼
Same method as FY2016 (see that record for the portfolio-purchase treatment). CFO=$15.475M; ΔWC=$(32.143)M so -ΔWC=+$32.143M; SBC=$8.678M; PP&E capex=$22.840M; portfolio purchases=$1,086.029M vs collections applied to principal=$717.170M -> purchases exceed collections, maintenance purchase=collections=$717.170M, net portfolio adjustment=$0 (purchases>=collections). OE=15.475+32.143-8.678-22.840=$16.100M. Diluted shares=45.823M. OE/sh=$0.35. Source: FY2017 10-K, accession 0001185348-18-000008 (figures as restated in FY2018 10-K, accession 0001185348-19-000009).
2016
$4.16
▼
PRA Group is a debt buyer; portfolio purchases sit in investing, not operating, so OE = CFO - ΔWC - SBC - PP&E capex - maintenance portfolio purchase, where maintenance portfolio purchase = min(portfolio purchases, collections applied to principal) (replacement-only; any purchases beyond principal collected are growth investment, not deducted, and if purchases fall short of collections the shortfall is added back as a harvest). CFO=$205.903M; ΔWC(other assets/receivables/AP/taxes/accrued/other liab)=$(7.544)M so -ΔWC=+$7.544M; SBC=$6.138M; PP&E capex=$14.160M (treated in full as maintenance; immaterial vs. revenue); portfolio purchases=$890.803M vs collections applied to principal=$646.844M -> purchases exceed collections (book growing) so maintenance portfolio purchase=$646.844M, harvest add-back=$0. OE=205.903+7.544-6.138-14.160-646.844+646.844(offsetting, net effect $0 since purchases>=collections)=$193.149M. Diluted shares=46.388M. OE/sh=$4.16. Source: FY2016 10-K, accession 0001185348-17-000012 (figures as restated in FY2018 10-K, accession 0001185348-19-000009).
Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.